Neladalkib (NVL-655, ALK-IN-27) is a novel, brain-permeable, selective ALK inhibitor with antitumor activity. For Ba/F3 CLIP1-LTK cells, NVL-655 has an IC50 of 2.7 nM. Neladalkib (NVL-655, ALK-IN-27) can be used in studies related to ALK-positive non-small cell lung cancer (NSCLC).
Molecular Weight:
452.91
Purity:
99.0%
CAS Number:
[2739866-40-9]
Formula:
C23H22ClFN6O
Target:
ALK
* VAT and and shipping costs not included. Errors and price changes excepted